enVVeno Medical Corp. has appointed Jennifer Bright as Chief Financial Officer, effective May 19, 2025. With over 25 years of experience in financial and strategic leadership across various medical device and pharmaceutical companies, Bright will oversee the company's financial strategy and operations. She succeeds Craig Glynn, who will remain with the company in an advisory role.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.